search for keywords
on the Pieris webpage

press releases 2006

  • December, 13 - Analysis by AlgoNomics reveals that Anticalins® intrinsically have an immunogenicity level comparable to the wild-type human lipocalin

  • October, 25 - Pieris confirms in vivo activity of potent VEGF specific Anticalin®

  • September, 27 - Crystallographic analysis of Anticalin® targeting CTLA-4 confirms the excellent suitability of Pieris’ lipocalin scaffold to develop superior biotherapeutics

  • July, 6 - Pieris reaches key milestones under the collaboration agreement with Syngenta
  • June, 21 - Pieris appoints Dr Andreas Hohlbaum as member of its management team

  • May, 17 - Pieris appoints new Chief Executive Officer

  • April, 21 - Pieris enters into a collaborative research and option agreement with GE Healthcare

 

press releases 2005

  • April, 13 - Pieris Proteolab AG and Syngenta Biopharma collaborate to develop Anticalins®

 

press releases 2004

  • March, 10 - In vivo proof of concept for Anticalins®
  • May, 7 - Pieris receives € 2 million grant from German Ministry of Education and Research (BMBF) 

  • September, 15 - Prof Arne Skerra, Dr Martin Pöhlchen and Dr Steffen Schlehuber nominated for the German Future Prize (Deutscher Zukunftspreis) 2004 of the German Federal President

 

 press releases 2003

  • July, 24 - Pieris Proteolab AG and Technical University of Munich announce strategic alliance in Anticalin® research
  • November, 18 - Pieris announces breakthrough in Anticalin® technology

 

press releases 2002

  • January, 24 - Pieris and CytoTools sign R&D collaboration agreement for the development of Anticalins® against novel targets in atherosclerosis 
  • October, 31 - Pieris Proteolab AG closes € 12 million financing round  

 

 

press releases 2001

  • July, 19 - Pieris Proteolab AG appoints Chief Executive Officer
  • October, 23 - Pieris wins award in the fifth round of the Biochance competition 
  • November, 5 - Pieris wins award during Biotech & Finance Conference in Paris
  • November, 13 - Pieris releases human Anticalin® library with more than 10 billion structures